亿帆医药：2’-岩藻糖基乳糖获国家卫健委审查通过

Core Viewpoint - Yifan Pharmaceutical (002019.SZ) announced that its wholly-owned subsidiary, Hangzhou Xinfu Technology Co., Ltd., received an administrative license review conclusion notice from the National Health Commission of the People's Republic of China, approving the application for 2'-fucosyllactose, a significant human milk oligosaccharide with various health benefits [1] Group 1 - The National Health Commission issued the administrative license review conclusion notice on December 4, 2025 [1] - The approval is based on the Food Safety Law and the Management Measures for New Varieties of Food Additives [1] - 2'-fucosyllactose is known for its functions in regulating gut microbiota, promoting brain development, and enhancing immunity [1]